+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

DNA & Gene Chip Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083536
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The DNA & gene chip market is evolving as organizations embrace advanced solutions to boost research productivity and diagnostic accuracy. Senior leaders are navigating operational, regulatory, and technological shifts that directly impact procurement, supply chain, and strategic investments in this dynamic sector.

Market Snapshot: DNA & Gene Chip Market Growth Overview

The DNA & gene chip market experienced notable growth from USD 10.84 billion in 2025 to USD 12.09 billion in 2026, with a sustained CAGR of 11.78%. Projections indicate an expansion to USD 23.64 billion by 2032. This growth is propelled by breakthroughs in chemistry, microfabrication, and analytics, influencing how stakeholders in clinical and research settings adapt procurement and operational strategies to leverage evolving technologies.

Scope & Segmentation

  • Product Categories: Microarray chips, microfluidic consumables, qPCR arrays, labeling and detection kits, analytics software, and related services all contribute to the breadth of market offerings.
  • Application Areas: These solutions are applied in diagnostics, gene expression profiling, genotyping, resequencing, and development of targeted disease panels, particularly for oncology, infectious disease, and genetic disorder applications.
  • End-User Segments: The ecosystem includes academic and research institutes, contract research organizations (CROs), hospitals and diagnostic labs, as well as both pharmaceutical and biotechnology companies.
  • Chip Architectures: Markets feature cDNA arrays supporting legacy use-cases and specific assays, and oligonucleotide arrays designed for current genotyping and high-density genomic analysis.
  • Regional Markets: Key regions—Americas, Europe, Middle East & Africa, and Asia-Pacific—show distinct regulatory requirements, healthcare infrastructure patterns, and manufacturing investments that shape adoption and implementation.
  • Technology Integration: Hybrid models merge traditional microarray platforms with next-generation sequencing, modular automation, enhanced surface chemistries, and interoperable data pipelines to address translational needs across organizations.

Key Takeaways: DNA & Gene Chip Market Strategic Insights

  • Integrated offerings combining consumables, analytical software, and supporting hardware are favored by organizations seeking comprehensive solutions for both diagnostics and research workflow efficiency.
  • Quality assurance, validation support, and regulatory readiness drive selection criteria, especially within clinical and translational research environments where reproducibility is essential.
  • Buyer preference is shifting toward suppliers offering robust post-analytical value through software, informatics, and service models, highlighting the importance of actionable data over hardware specifications alone.
  • Regional policies and procurement standards require adaptable go-to-market models and emphasize the need for local technical support to succeed across global markets.
  • Risk mitigation practices, such as supply-chain resilience and the ability to respond to regulatory updates, are key for vendors aiming to maintain preferred status with laboratories and institutional buyers.

Tariff Impact: Shifting Sourcing and Validation Across the DNA & Gene Chip Supply Chain

Following the introduction of targeted tariff measures in 2025, sourcing strategies have shifted considerably. Buyers are placing greater emphasis on domestic and nearshore manufacturing to limit exposure to tariffs and reduce customs-related volatility. Procurement contracts now frequently address tariff pass-through and flexibility in component substitution to minimize supply disruptions. Inventory management is evolving, with organizations increasing safety stock to buffer against potential cost fluctuations or delivery delays. To ensure consistent product availability, validation processes are expanding to include alternative components and assembly locations, underscoring the importance of supplier agility and regional regulatory expertise.

Methodology & Data Sources

This analysis employs a mixed-methods framework, combining interviews with laboratory and procurement leads, regulatory reviews, and detailed segmentation. Data accuracy is reinforced through triangulation using supplier input, end-user feedback, literature evaluation, and public disclosures, ensuring reliable and actionable market intelligence.

Why This Report Matters to Senior Decision-Makers

  • Delivers a strategic overview of operational, technology, and regulatory drivers shaping DNA & gene chip market direction.
  • Provides intelligence to support procurement and commercial choices in line with evolving organizational priorities and regional constraints.
  • Informs supply-chain, validation, and market-entry strategies to manage risk, achieve growth, and solidify market positioning.

Conclusion

Sustained growth in the DNA & gene chip sector depends on agile technology adoption, robust supply chains, and proactive regulatory navigation. Aligning with these requirements positions organizations for continued innovation and operational strength.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. DNA & Gene Chip Market, by Product
8.1. Labeling And Detection Kits
8.2. Microarray Chips
8.3. Microfluidics Consumables
8.4. qPCR Arrays
8.5. Software And Services
9. DNA & Gene Chip Market, by Chip Type
9.1. cDNA Arrays
9.2. Oligonucleotide Arrays
10. DNA & Gene Chip Market, by Application
10.1. Diagnostics
10.1.1. Cancer Diagnostics
10.1.2. Genetic Disorder Diagnostics
10.1.3. Infectious Disease Diagnostics
10.2. Gene Expression Profiling
10.3. Genotyping
10.4. Resequencing
11. DNA & Gene Chip Market, by End User
11.1. Academic And Research Institutes
11.2. Contract Research Organizations
11.3. Hospitals And Diagnostic Laboratories
11.4. Pharmaceutical And Biotechnology Companies
12. DNA & Gene Chip Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. DNA & Gene Chip Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. DNA & Gene Chip Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States DNA & Gene Chip Market
16. China DNA & Gene Chip Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Agilent Technologies, Inc.
17.6. BGI Genomics Co., Ltd
17.7. Bio-Rad Laboratories, Inc.
17.8. Danaher Corporation
17.9. F. Hoffmann-La Roche Ltd
17.10. Greiner Bio-One International GmbH
17.11. Illumina, Inc.
17.12. Integrated Dna Technologies
17.13. LifeGen Technologies, LLC
17.14. Macrogen Inc.
17.15. PerkinElmer, Inc.
17.16. QIAGEN N.V.
17.17. Takara Bio Inc.
17.18. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES DNA & GENE CHIP MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA DNA & GENE CHIP MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, BY LABELING AND DETECTION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY LABELING AND DETECTION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY LABELING AND DETECTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DNA & GENE CHIP MARKET SIZE, BY MICROARRAY CHIPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY MICROARRAY CHIPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY MICROARRAY CHIPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY MICROFLUIDICS CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY MICROFLUIDICS CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY MICROFLUIDICS CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY QPCR ARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY QPCR ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DNA & GENE CHIP MARKET SIZE, BY QPCR ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CDNA ARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CDNA ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CDNA ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DNA & GENE CHIP MARKET SIZE, BY OLIGONUCLEOTIDE ARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DNA & GENE CHIP MARKET SIZE, BY OLIGONUCLEOTIDE ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DNA & GENE CHIP MARKET SIZE, BY OLIGONUCLEOTIDE ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENETIC DISORDER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENETIC DISORDER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENETIC DISORDER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DNA & GENE CHIP MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DNA & GENE CHIP MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DNA & GENE CHIP MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DNA & GENE CHIP MARKET SIZE, BY RESEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DNA & GENE CHIP MARKET SIZE, BY RESEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DNA & GENE CHIP MARKET SIZE, BY RESEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS DNA & GENE CHIP MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. EUROPE DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. EUROPE DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 88. EUROPE DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 89. EUROPE DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 90. EUROPE DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 91. EUROPE DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 100. AFRICA DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 101. AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. AFRICA DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 103. AFRICA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. ASEAN DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASEAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 113. ASEAN DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASEAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. ASEAN DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 116. ASEAN DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. GCC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GCC DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 119. GCC DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 120. GCC DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. GCC DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 122. GCC DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. BRICS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. BRICS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 131. BRICS DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 132. BRICS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. BRICS DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 134. BRICS DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. G7 DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. G7 DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 137. G7 DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 138. G7 DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. G7 DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 140. G7 DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. NATO DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. NATO DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 143. NATO DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 144. NATO DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. NATO DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 146. NATO DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. UNITED STATES DNA & GENE CHIP MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 149. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 150. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 151. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 153. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. CHINA DNA & GENE CHIP MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 155. CHINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 156. CHINA DNA & GENE CHIP MARKET SIZE, BY CHIP TYPE, 2018-2032 (USD MILLION)
TABLE 157. CHINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. CHINA DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 159. CHINA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this DNA & Gene Chip market report include:
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Greiner Bio-One International GmbH
  • Illumina, Inc.
  • Integrated Dna Technologies
  • LifeGen Technologies, LLC
  • Macrogen Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Table Information